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The purpose of this study was to examine the structural abnormalities of patients with late-onset major
depressive disorder using brain magnetic resonance imaging (MRI) and to assess clinical correlates of
these structural abnormalities. Thirty-seven elderly patients with DSM-IV major depressive disorder that
first occurred after the age of 50 years, and 18 control subjects without depression were recruited. All
participants underwent comprehensive psychiatric assessment and cerebral MRI. Brain ventricular and
sulcal sizes and white matter hyperintensities were assessed visually. Relative to control subjects, patients
with late-life major depressive disorder showed more severe brain atrophy (p = 0.043) and white matter
hyperintensities (p = 0.024), especially in the periventricular area (p = 0.012). Over 60% of the patient group
had significant brain MRI hyperintensities. White matter hyperintensity was correlated with later onset
of depressive illness (r = 0.49, p = 0.002) among patients. Brain atrophy and white matter hyperintensities
are prevalent in patients with late-onset major depressive disorders. These two abnormalities may
represent different pathophysiologic processes of depressive disorders. White matter hyperintensities
may be predisposing factors for late-onset major depressive disorder.
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Late-life major depressive disorder is associated with greater
risk of disability, morbidity, and mortality, has been
identified as a major public health problem [1], and is
heterogeneous in clinical presentation, etiology, and clinical
outcome. For example, some late-life depressives present
with the first depressive episode in late life, while others
have had recurrent depression from a young age. There are
different risk profiles between these two groups. Compared
to early-onset late-life depressives, patients with late-onset
major depressive disorder appear to have more comorbidity
with vascular disease [2], more cognitive impairment [3,4],
and a higher rate of dementia on follow-up [5]. Neuro-
biologic processes in the brain may play a crucial role in the
occurrence of late-onset major depressive disorder.
The brain abnormalities of brain atrophy and white matter
hyperintensities on magnetic resonance imaging (MRI) are
common among patients with late-life depression [6–8] and
are considered to represent relatively independent pathways
to late-life major depression [9]. Smaller brain volume is seen
in subjects with earlier age of depression onset, and recurrent
or chronic depression may have a neurotoxic effect on brain
tissue [10]. White matter hyperintensities are considered a
predisposing factor for late-onset depression [11].
© 2005 Elsevier. All rights reserved.
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We conducted this case–control study to investigate the
brain structural abnormalities detected by MRI in patients
with late-onset major depressive disorder, as compared to
healthy elders. We also attempted to characterize clinical
correlates of brain abnormalities among depressive elders,
in order to provide some information on the relationship
between anatomy and psychopathology. We hypothesized
that brain atrophy and white matter hyperintensities would
be more prominent in late-onset major depressive disorder.
Older age at onset of major depression would be correlated
with the severity of white matter hyperintensities, while
brain atrophy would be greater in patients experiencing the
first episode of major depressive disorder earlier in life.
PATIENTS AND METHODS
Thirty-seven consecutive elders aged 60 years or more with
late-onset major depressive disorder and who were seen at one
teaching hospital psychiatric clinic were recruited, while 18
volunteer elderly subjects aged 60 years or more without any
mental or neurologic disorders or history were used as controls.
Each study participant underwent physical examination,
routine biochemistry testing, and psychiatric interview by one
psychiatrist using the Chinese version of the Geriatric Mental
State Schedule [12], and diagnosis was made according to
DSM-IV criteria [13]. Depression severity was measured using
the 17-item Hamilton Rating Scale for Depression (HRSD)
[14]. A questionnaire to ascertain any history of vascular
diseases such as hypertension, diabetes mellitus, heart
disease, and hyperlipidemia was also administered.
The inclusion criteria were that subjects’ current age
was at least 60 years, there was a diagnosis of major
depressive disorder, a current HRSD score of at least 15, and
an age of at least 50 years at the onset of major depressive
disorder. Cases with another DSM-IV Axis I diagnosis or a
clinical history of major neurologic illness (such as stroke,
Parkinson’s disease, epilepsy, traumatic head injury) were
excluded. Control subjects were recruited by advertisement
and underwent the same assessment as the case group.
They had no psychiatric diagnosis according to DSM-IV.
The research protocol was approved by the institutional
review board of Kaohsiung Medical University, and written
informed consent was obtained from each participant.
MRI acquisition and rating
MRI scans were obtained on a 3-T scanner (Signa VH3, GE
Medical Systems, Milwaukee, WI, USA). Spin-echo T1-
weighted axial and sagittal images (TR 484, TE 8–9 msec; two
signals acquired; matrix size 256 × 192; section thickness
7 mm; intersection gap 0 mm), fast spin-echo T2-weighted
axial images (TR 4000, TE 98 msec; two signals acquired;
matrix size 256 × 256; section thickness 7 mm; intersection
gap 0 mm), and fluid-attenuated inversion recovery and
diffusion-weighted axial images with single-shot echo-planar
imaging (TR/TE 10,000/minimum; b = 0, 1,000; field of view
30; slice thickness 5 mm; intersection gap 1 mm) were obtained.
Brain MRI studies were rated by a radiologist blinded to
clinical data. Brain atrophy on MRI was assessed according
to the Cardiovascular Health Study (CHS) protocol [15,16],
while Fazekas criteria were used to assess the severity of
white matter hyperintensities [17]. Ischemic infarctions were
defined as the presence of infarct-like lesions. Variables
estimated in the CHS protocol were ventricular and sulcal
size on a 10-point scale (0–9). Cerebral ventricular size was
assessed on a scale of 0–9 with successively increasing
ventricular size ranging from small and presumably normal
(grade 1) to severe enlargement (grade 8). Grade 0 was
considered smaller than grade 1, while grade 9 was worse
than grade 8. The assessment for sulcal widening was
similar. A composite grade of ventricular size and sulcal
size was the indicator of brain atrophy. The Fazekas scale
was used to measure hyperintensities in periventricular
white matter (PWM) and deep white matter (DWM). PWM
hyperintensities were graded as absent (grade 0), cap (grade
1), smooth halo (grade 2), or irregular and extending into
DWM (grade 3); DWM hyperintensities were graded as
absent (grade 0), punctate foci (grade 1), early-confluent
(grade 2), or confluent (grade 3). A score of 2 or more in any
area was counted as a significant white matter hyperintensity
[11]. The intrarater reliability represented by intraclass
correlation coefficient of MRI hyperintensities in two regions
and brain atrophy rating ranged from 0.80 to 0.89.
Statistical analysis
Student’s t test or Chi-squared analysis was used to compare
demographic data between the patient and control groups.
Bivariate correlations were calculated using Pearson’s
product-moment analysis. The alpha criterion for
significance was 0.05 or less.
RESULTS
There were no statistical differences in gender distribution,
age, marital status, and education between the two groups
(Table 1). The depressive elderly scored lower on the Mini
Mental State Examination (MMSE) and were more likely to
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have at least one vascular disease, but the difference was
not statistically significant. The mean age at onset of the first
episode of major depressive disorder was 63.7 ± 9.7 years,
and mean HRSD score was 21.9 ± 6.6 in the patient group.
Table 2 compares brain structural abnormalities in terms
of ventricular size, sulcal size, white matter hyperintensities,
and infarction lesions. Patients had more severe total brain
atrophy (10.88 ±  2.58) than controls (9.29 ±  2.49). White
matter hyperintensities were also more severe in patients
compared to controls. The hyperintensities were more
prominent in the PWM (1.52 ±  0.80) than in the DWM
(0.88 ± 0.74). Twenty-three patients (62.2%) had significant
white matter hyperintensities. Brain infarct lesions were
observed in four patients (10.8%) and one control subject
(5.6%), but the difference was not significant (r2 = 0.49, p =
0.486). Cerebral MRIs of a patient aged 77 years and a
control subject aged 78 years are shown in Figure 1.
Total brain atrophy and white matter hyperintensities
were selected for further analysis for clinical correlates. For
patients, total HRSD and MMSE scores were not correlated
with either total brain atrophy or white matter hyper-
intensities. Age at onset was not correlated with total brain
atrophy (r = 0.21, p = 0.218) (Figure 2), but later onset was
associated with more severe white matter hyperintensi-
ties (r = 0.49, p = 0.002) (Figure 3). Duration since onset of
major depressive disorder was not correlated with total
brain atrophy (r = 0.07, p = 0.673).
DISCUSSION
In this clinical study, brain structural abnormalities were
more prominent in patients with late-onset major depressive
disorder compared with healthy control subjects. The
abnormalities reflected an excess of total brain atrophy and
white matter hyperintensities, especially in periventricular
regions. Over 60% of subjects with late-onset major
depressive disorder had significant white matter hyper-
intensities. More severe white matter hyperintensities were
associated with later onset of depressive illness.
Table 2. Magnetic resonance imaging ratings in patients with late-onset major depressive disorder (MDD) and controls
Controls (n = 18) Late-onset MDD (n = 37) t or r2 p
CHS classification
Total atrophy 9.29 ± 2.49 10.88 ± 2.58 2.08 0.043
Sulcal widening 4.94 ± 1.64 5.82 ± 1.51 1.89 0.065
Ventricular dilation 4.35 ± 1.62 5.06 ± 1.48 1.55 0.127
Fazekas classification
Total 1.67 ± 1.14 2.57 ± 1.44 2.32 0.024
PWMH 0.88 ± 0.86 1.52 ± 0.80 2.60 0.012
DWMH 0.88 ± 0.70 0.88 ± 0.74 0.02 0.987
Brain infarct 1 (5.9%) 4 (12.1%) 0.49 0.486
CHS = Cardiovascular Health Study; PWMH = periventricular white matter hyperintensities; DWMH = deep white matter hyperintensities.
Table 1. Univariate analysis for demographic and clinical features
Controls (n = 18) Late-onset MDD (n = 37) t or r2 p
Gender (female) 12 (66.7%) 23 (62.2%) 0.01 0.948
Age (yr) 70.2 ± 4.7 72.2 ± 3.6 1.64 0.108
Education (yr) 5.9 ± 5.2 5.3 ± 4.6 0.45 0.658
Married 12 (66.7%) 17 (45.9%) 1.68 0.196
Presence of vascular related disease 12 (66.7%) 25 (67.6%) 0.16 0.693
MMSE 28.4 ± 1.4 27.6 ± 1.7 1.63 0.109
17-item HRSD 3.7 ± 3.3 21.9 ± 6.6 10.63 0.001
Age at onset (yr) – 63.7 ± 9.7 – –
Years since onset – 8.5 (8.8) – –
MDD = major depressive disorder; MMSE= Mini Mental State Examination; HRSD = Hamilton Rating Scale for Depression.
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Our findings, which show the high frequency of white
matter hyperintensities and brain atrophy in individuals
with late-onset major depressive disorders, are consistent
with previous studies [18–21]. Over 60% of the patient
group had white matter hyperintensities, which is consistent
with most but not all of the studies in the literature [18–22].
The brain structural abnormalities more prominently seen
Figure 3. Correlation between white matter hyperintensities and age of
depression onset among patients with late-onset major depressive disorder.
Figure 1. Examples of T2-weighted magnetic resonance imaging of (A) a patient aged 77 years with prominent brain atrophy and white matter
hyperintensities, and (B) a control subject aged 78 years.
Figure 2. Correlation between brain ventricular and sulcal size and age of
depression onset among patients with late-onset major depressive disorder.
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examining the clinical correlates of brain structural
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abnormalities, and found that white matter hyperintensity
was associated with later age at onset of major depression.
Since depressed patients with white matter hyperintensities
had a limited duration of being in a depressed state and less
exposure to psychiatric treatment, it is likely that white
matter hyperintensity is more of a reflection of the etiologic
factors that produce the depressive syndrome than an
adverse consequence of being depressed.
T2-weighted hyperintensities are associated with
reduced regional cerebral vascular flow in the cerebral
cortex [23,24]. Given that increased hyperintensity severity
correlates strongly with cerebrovascular risk factors
[17,25], vascular mechanisms or vascular pathology have
been considered as a factor that causes a subgroup of late-
life major depressive disorder, and a subtype of vascular
depression has been proposed [11,26]. Pathologic ischemic
changes associated with white matter hyperintensities
have also been suggested [27–29]. The ischemic change
may interrupt the frontostriatal pathway that regulates
mood and produce depressive symptoms [30]. The fact
that hyperintensities damage the structure of brain tissue
was also supported by a recent diffusion tensor imaging
study [31]. Thus, our findings support the vascular
depression hypothesis, which suggests that vascular
pathology is a predisposing factor for late-life depression
[26].
It is possible that the causes of brain atrophy in depressed
elders include an active neurodegenerative process or the
effects of chronic disease on brain structure [9,32]. However,
our results did not find a correlation between brain atrophy
and any clinical features, including duration of illness.
Depressed patients with brain atrophy, especially in the
hippocampus, are reportedly more likely to develop
dementia [33]. We attempted to assess the relationship
between cognitive function and severity of brain atrophy in
depressed patients by calculating the correlation coefficients.
However, the relationship was negative. This negative
association may be because we confined patients to those
with an MMSE score of more than 24, in order to exclude
patients with prominent cognitive impairment. Requiring
high MMSE scores for study inclusion decreased the
likelihood of observing significant associations between
MMSE scores and brain atrophy. Hence, even though the
correlations between MMSE score and brain atrophy did
not reach significance, it is possible that depressed patients
with more severe brain atrophy are at greater risk of
developing cognitive decline or Alzheimer’s disease on
follow-up. Further prospective studies are needed to address
this possibility.
One limitation of this study was the small sample size,
which may lead to a greater type I statistical error. In
addition, enlarged ventricular and sulcal size does not
always reflect atrophic pathogenesis. More precise MRI
volumetry would be an alternative and better method to
define brain atrophy. Moreover, a cross-sectional design
may limit the cause–effect inference. Although we tried to
determine the cause–effect issue by calculating the
association of brain abnormalities and clinical correlates,
further prospective investigations with a larger sample size
using MRI volumetry are needed to replicate the findings of
this study.
In conclusion, this study found a relatively high rate of
brain abnormalities, including white matter hyperintensities
and brain atrophy, in patients with late-onset major
depressive disorder relative to control subjects. White matter
hyperintensities may be a predisposing factor for late-onset
major depressive disorder.
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